|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
LIN,JING-YI | CHANG,KAI-HSUN | HSU,HUO-WANG | (04)2496-3666 | No. 190, Gongye 9th Rd.,Dali Dist, Taichung City 412, Taiwan | 2018/07/12 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Founded in 1979,CVC is one of the biggest brand in pharmaceutical machinery industry;with more than 10,000 machines sold, CVC's equipments are popularly adopted by drug-makers worldwide.CVC'S pharmaceutical packaging product offering includes tablet/capsule bottling line,liquid filling line,powder filling line,tube filling equipment and various types of labeling system.Not just manufacturing equipments, CVC is the total solution provider to work out all issues of software, hardware and turnkey integration of pharmaceutical packaging equipments.In 2008, CVC brought in the vision inspection technology and launched the product line of syringe inspection system.CVC expanded its business to laboratory instrument in 2008 via merger of Micro-Tech Scientific Inc.,the US based HPLC company and acquired its patented technologies in Nano LC systems. The new brand,CVC-MicroTech provides Nano XPLC,MS,auto-sampler,UV detector,fraction collector,columns and accessories of HPLC systems. |
Market Information ( 2024/04/25 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
114.635 | 24.10 | 23.90 | 23.95 | -0.05 | 81 | .00 | 3,761 | 1 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/25) |
TPEx measures adopted (2024/04/25) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |